McKesson - MCK Stock Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MCK shares.
View MCK analyst ratings or view top-rated stocks.

9 Wall Street analysts have issued 1-year target prices for McKesson's shares. Their MCK share price forecasts range from $376.00 to $450.00. On average, they anticipate the company's stock price to reach $416.30 in the next twelve months. This suggests a possible upside of 19.1% from the stock's current price.
View analysts price targets for MCK or view top-rated stocks among Wall Street analysts.

McKesson's stock was trading at $375.12 at the beginning of 2023. Since then, MCK stock has decreased by 6.9% and is now trading at $349.40.
View the best growth stocks for 2023 here.

McKesson saw a decrease in short interest in the month of February. As of February 15th, there was short interest totaling 2,210,000 shares, a decrease of 18.1% from the January 31st total of 2,700,000 shares. Based on an average daily volume of 1,000,000 shares, the days-to-cover ratio is currently 2.2 days. Approximately 1.6% of the company's shares are short sold.
View McKesson's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our MCK earnings forecast.

McKesson Co. (NYSE:MCK) released its earnings results on Wednesday, February, 1st. The company reported $6.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.36 by $0.54. The company earned $70.49 billion during the quarter, compared to the consensus estimate of $70.98 billion. McKesson had a net margin of 1.15% and a negative trailing twelve-month return on equity of 216.12%. The business's revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the business earned $6.15 EPS.
Read the conference call transcript.

McKesson declared a quarterly dividend on Thursday, January 26th. Investors of record on Wednesday, March 1st will be given a dividend of $0.54 per share on Monday, April 3rd. This represents a $2.16 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Tuesday, February 28th.
Read our dividend analysis for MCK.

ETFs with the largest weight of McKesson (NYSE:MCK) stock in their portfolio include Alger Mid Cap 40 ETF (FRTY), VanEck Pharmaceutical ETF (PPH), Vesper U.S. Large Cap Short-Term Reversal Strategy ETF (UTRN), First Trust Consumer Staples AlphaDEX Fund (FXG), VanEck Retail ETF (RTH), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), iShares US Consumer Staples ETF (IYK) and AdvisorShares Dorsey Wright Alpha Equal Weight ETF (DWEQ).

McKesson (NYSE:MCK) pays an annual dividend of $2.16 per share and currently has a dividend yield of 0.62%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MCK will have a dividend payout ratio of 8.21% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MCK.

McKesson issued an update on its FY23 earnings guidance on Wednesday, February, 1st. The company provided earnings per share guidance of $25.75-26.15 for the period, compared to the consensus earnings per share estimate of $24.80.

220 employees have rated McKesson Chief Executive Officer Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson's stock is owned by a variety of institutional and retail investors. Top institutional investors include Berkshire Hathaway Inc (2.09%), Geode Capital Management LLC (1.83%), Morgan Stanley (1.57%), Putnam Investments LLC (1.42%), Norges Bank (1.23%) and LSV Asset Management (0.86%). Insiders that own company stock include Brian S Tyler, Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Lori A Schechter, Marie L/Ca Knowles, Nancy Avila, Nancy Flores, Sundeep G Reddy, Sundeep G Reddy, Thomas L Rodgers, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends.

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MCK stock can currently be purchased for approximately $349.40.

McKesson (NYSE:MCK) has a market capitalization of $47.85 billion and generates $263.97 billion in revenue each year. The company earns $1.11 billion in net income (profit) each year or $21.87 on an earnings per share basis.

The company employs 75,000 workers across the globe.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The official website for the company is www.mckesson.com. The company can be reached via phone at (972) 446-4800, via email at investors@mckesson.com, or via fax at 415-983-8453.